000 | 01605 a2200445 4500 | ||
---|---|---|---|
005 | 20250512005557.0 | ||
264 | 0 | _c19890228 | |
008 | 198902s 0 0 eng d | ||
022 | _a0006-3223 | ||
024 | 7 |
_a10.1016/0006-3223(89)90149-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThaker, G K | |
245 | 0 | 0 |
_aAlterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism. _h[electronic resource] |
260 |
_bBiological psychiatry _cJan 1989 |
||
300 |
_a75-86 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xphysiopathology |
650 | 0 | 4 | _aElectroencephalography |
650 | 0 | 4 |
_aHaloperidol _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoquinolines _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProlactin _xblood |
650 | 0 | 4 |
_aReaction Time _xdrug effects |
650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
650 | 0 | 4 | _aReceptors, Dopamine D2 |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 |
_aSleep Stages _xdrug effects |
650 | 0 | 4 |
_aSleep, REM _xdrug effects |
650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xphysiopathology |
700 | 1 | _aWagman, A M | |
700 | 1 | _aKirkpatrick, B | |
700 | 1 | _aTamminga, C A | |
773 | 0 |
_tBiological psychiatry _gvol. 25 _gno. 1 _gp. 75-86 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-3223(89)90149-2 _zAvailable from publisher's website |
999 |
_c2569179 _d2569179 |